Johnson M, Younan D, Kent ST, Frias MM, et al. Corrigendum to "Real-world comparative effectiveness of sotorasib versus docetaxel in second line and beyond among patients with advanced non-small cell lung cancer (NSCLC)" [Lung Cancer 197 (2024) 107960]. Lung Cancer 2025 Feb 20:108440. doi: 10.1016/j.lungcan.2025.108440.
PMID: 39984314